Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick J Peller

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
American Journal of Nuclear Medicine and Molecular Imaging|November 29, 2017
The flip-flop fungus sign: an FDG PET/CT sign of benignityAlex A Nagelschneider, Stephen M Broski, William P Holland, et al.
Clinical Lymphoma & Myeloma|May 27, 2008
The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphomaDimitrios Karantanis, Rathan M Subramaniam, Patrick J Peller, et al.
Nuclear Medicine Communications|September 29, 2007
18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patientsDimitrios Karantanis, Brian P O'eill, Rathan M Subramaniam, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2010
North Central Cancer Treatment Group Phase I trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiformeJann N Sarkaria, Evanthia Galanis, Wenting Wu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2007
Clinical significance of diffusely increased 18F-FDG uptake in the thyroid glandDimitrios Karantanis, Trond V Bogsrud, Gregory A Wiseman, et al.
Clinical Nuclear Medicine|December 10, 2015
ACR-ASNR Practice Parameter for Brain PET/CT Imaging DementiaKirk A Frey, Martin A Lodge, Carolyn Cidis Meltzer, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|November 11, 2014
Malignant involvement of the peripheral nervous system in patients with cancer: multimodality imaging and pathologic correlationAndrew Bryce Crush, Benjamin Matthew Howe, Robert J Spinner, et al.
Neurology|May 7, 2013
Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNIVal J Lowe, Patrick J Peller, Stephen D Weigand, et al.
Neuro-Oncology|December 21, 2014
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057KDaniel J Ma, Evanthia Galanis, S Keith Anderson, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2021
Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance])Harry H Yoon, Fang-Shu Ou, Gamini S Soori, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
American Journal of Nuclear Medicine and Molecular Imaging|November 29, 2017
The flip-flop fungus sign: an FDG PET/CT sign of benignityAlex A Nagelschneider, Stephen M Broski, William P Holland, et al.
Clinical Lymphoma & Myeloma|May 27, 2008
The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphomaDimitrios Karantanis, Rathan M Subramaniam, Patrick J Peller, et al.
Nuclear Medicine Communications|September 29, 2007
18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patientsDimitrios Karantanis, Brian P O'eill, Rathan M Subramaniam, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2010
North Central Cancer Treatment Group Phase I trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiformeJann N Sarkaria, Evanthia Galanis, Wenting Wu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2007
Clinical significance of diffusely increased 18F-FDG uptake in the thyroid glandDimitrios Karantanis, Trond V Bogsrud, Gregory A Wiseman, et al.
Clinical Nuclear Medicine|December 10, 2015
ACR-ASNR Practice Parameter for Brain PET/CT Imaging DementiaKirk A Frey, Martin A Lodge, Carolyn Cidis Meltzer, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|November 11, 2014
Malignant involvement of the peripheral nervous system in patients with cancer: multimodality imaging and pathologic correlationAndrew Bryce Crush, Benjamin Matthew Howe, Robert J Spinner, et al.
Neurology|May 7, 2013
Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNIVal J Lowe, Patrick J Peller, Stephen D Weigand, et al.
Neuro-Oncology|December 21, 2014
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057KDaniel J Ma, Evanthia Galanis, S Keith Anderson, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2021
Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance])Harry H Yoon, Fang-Shu Ou, Gamini S Soori, et al.
Pageof 4